Standard BioTools Inc. (LAB) 

NASDAQ$1.3
Market Cap
$496.59M
Sector
Healthcare
Industry
Medical—Diagnostics & Research
Rank in Sector
58 of 840
Rank in Industry
1 of 44

LAB Insider Trading Activity

LAB Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$6,871,901
9
50
Sells
$57,509
9
50

Related Transactions

Casdin Partners Master Fund, L.P.
9
$6.87M
0
$0
$6.87M
Kim Hanjoon AlexChief Financial Officer
0
$0
3
$4,151
$-4,151
Egholm MichaelPresident & CEO
0
$0
3
$15,137
$-15,137
Mackay SeanSVP & Chief Business Officer
0
$0
3
$38,221
$-38,221

About Standard BioTools Inc.

Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpar on demand reagents, and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as Juno systems; and analytical â€¦

Insider Activity of Standard BioTools Inc.

Over the last 12 months, insiders at Standard BioTools Inc. have bought $6.87M and sold $57,509 worth of Standard BioTools Inc. stock.

On average, over the past 5 years, insiders at Standard BioTools Inc. have bought $10.52M and sold $285,759 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Casdin Partners Master Fund, L.P. () — $6.87M.

The last purchase of 250,000 shares for transaction amount of $319,350 was made by Casdin Partners Master Fund, L.P. () on 2025‑09‑04.

List of Insider Buy and Sell Transactions, Standard BioTools Inc.

2025-09-04PurchaseCasdin Partners Master Fund, L.P.
250,000
0.0648%
$1.28
$319,350
+0.39%
2025-09-03PurchaseCasdin Partners Master Fund, L.P.
250,000
0.0642%
$1.27
$316,400
+0.19%
2025-08-26PurchaseCasdin Partners Master Fund, L.P.
125,000
0.0326%
$1.26
$157,938
0.00%
2025-08-25PurchaseCasdin Partners Master Fund, L.P.
200,000
0.0512%
$1.24
$248,180
+4.03%
2025-08-22PurchaseCasdin Partners Master Fund, L.P.
200,000
0.0521%
$1.26
$252,680
+1.57%
2025-08-15PurchaseCasdin Partners Master Fund, L.P.
150,000
0.0392%
$1.22
$183,210
+3.25%
2025-08-14PurchaseCasdin Partners Master Fund, L.P.
133,220
0.0349%
$1.21
$161,543
+4.10%
2025-08-13PurchaseCasdin Partners Master Fund, L.P.
75,000
0.0198%
$1.31
$98,280
-3.05%
2025-05-23SaleEgholm MichaelPresident & CEO
5,473
0.0015%
$0.94
$5,150
+36.72%
2025-05-23SaleKim Hanjoon AlexChief Financial Officer
1,428
0.0004%
$0.94
$1,344
+36.72%
2025-05-23SaleMackay SeanSVP & Chief Business Officer
13,217
0.0036%
$0.94
$12,437
+36.72%
2025-05-22SaleEgholm MichaelPresident & CEO
5,116
0.0014%
$1.00
$5,126
+32.01%
2025-05-22SaleKim Hanjoon AlexChief Financial Officer
1,355
0.0004%
$1.00
$1,358
+32.01%
2025-05-22SaleMackay SeanSVP & Chief Business Officer
12,536
0.0035%
$1.00
$12,561
+32.01%
2025-05-21SaleEgholm MichaelPresident & CEO
4,719
0.0012%
$1.03
$4,861
+21.15%
2025-05-21SaleKim Hanjoon AlexChief Financial Officer
1,407
0.0004%
$1.03
$1,449
+21.15%
2025-05-21SaleMackay SeanSVP & Chief Business Officer
12,838
0.0033%
$1.03
$13,223
+21.15%
2025-02-28PurchaseCasdin Partners Master Fund, L.P.
4.82M
1.2482%
$1.06
$5.13M
+8.88%
2024-08-27PurchaseCasdin Partners Master Fund, L.P.
250,000
0.0798%
$2.19
$546,750
-37.84%
2024-08-26PurchaseCasdin Partners Master Fund, L.P.
150,000
0.0471%
$2.15
$322,455
-37.33%
Total: 445
*Gray background shows transactions not older than one year

Insider Historical Profitability

11.17%
Casdin Partners Master Fund, L.P.
60775000
15.9099%
$79.01M360
<0.0001%
Caligan Partners LP10 percent owner
11444836
2.9961%
$14.88M180
<0.0001%
JOHNSON DAVID EDWARD
11189663
2.9293%
$14.55M80
<0.0001%
LEVIN CAPITAL STRATEGIES, L.P.10 percent owner
10473809
2.7419%
$13.62M1110
+23.89%
TORRAY ROBERT Edirector
2381164
0.6233%
$3.1M40
HAYWARD ALFRED O JRCEO of LaBranche & Co LLC
1881468
0.4925%
$2.45M10
Casdin Eli
1200000
0.3141%
$1.56M30
+12.56%
BURKE WILLIAM J IIIChief Operating Officer
571036
0.1495%
$742,346.8040
COLELLA SAMUEL Ddirector
161109
0.0422%
$209,441.70115
+11.04%
BARTHELEMY NICOLASdirector
149373
0.0391%
$194,184.9021
+82.84%
Linthwaite Stephen ChristopherPresident & CEO
145347
0.038%
$188,951.1031
+13.41%
Black Jeffrey G.SVP & Chief Financial Officer
85984
0.0225%
$111,779.2020
+7.31%
JONES EVAN/ FAdirector
53551
0.014%
$69,616.3099
+16.87%
JOG VIKRAMCHIEF FINANCIAL OFFICER
52061
0.0136%
$67,679.30126
+89.16%
McPhail StevenChief Commercial Officer
27842
0.0073%
$36,194.6010
+89.16%
ROBBINS STUART Mdirector
5000
0.0013%
$6,500.0010
Smith William MaxwellEVP, LEGAL AFFAIRS & GC
1389
0.0004%
$1,805.70164
<0.0001%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

Standard BioTools Inc.
(LAB)
$71,161,299
197
11.17%
$496.59M
$26,663,659
7
-12.13%
$23.06B
$66,999
2
-47.54%
$11.52M
$99,997
1
-77.35%
$6.8M

LAB Institutional Investors: Active Positions

Increased Positions76+46.91%11M+3.95%
Decreased Positions61-37.65%12M-4.32%
New Positions29New2MNew
Sold Out Positions14Sold Out746,732Sold Out
Total Postitions177+9.26%282M-0.36%

LAB Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Casdin Capital, Llc$95,855.0019.92%76.08M00%2025-06-30
Viking Global Investors Lp$73,900.0015.35%58.65M00%2025-06-30
Blackrock, Inc.$31,279.006.5%24.82M+204,489+0.83%2025-06-30
Vanguard Group Inc$21,397.004.45%16.98M-243,512-1.41%2025-06-30
Long Focus Capital Management, Llc$12,688.002.64%10.07M+3M+50.3%2025-06-30
Geode Capital Management, Llc$9,376.001.95%7.44M+235,677+3.27%2025-06-30
State Street Corp$7,940.001.65%6.3M-57,832-0.91%2025-06-30
Morgan Stanley$7,845.001.63%6.23M-4M-41.87%2025-06-30
Sumitomo Mitsui Trust Group, Inc.$7,769.001.61%6.17M-68,156-1.09%2025-06-30
Nikko Asset Management Americas, Inc.$7,757.001.61%6.16M-77,591-1.25%2025-06-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.